Artículos relacionados
![](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/thumbnail/S0001731023000819:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9/t1/zx4Q/XH5Tma1a/6fSs=)
Área salud
Wide Excision in Hidradenitis Suppurativa. Does it Modify the Course of Disease?
septiembre 26, 2023
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 114. Núm. 6. (Junio 2023)
There is a lack of studies assessing whether wide excision surgery in hidradenitis suppurativa affected areas is useful for the global control of the hidradenitis suppurativa. We aimed to find whether surgery results were a […]
Área salud
Experience with erenumab: Data from real clinical practice
diciembre 27, 2022
Área salud, Elsevier España, Medicina, Neurology Perspectives, Vol. 2. Issue. 3. (July - September 2022)
Introduction The development of monoclonal antibodies against calcitonin gene-related peptide has represented a revolution in the treatment of migraine. Erenumab was the first of these drugs to be available in clinical practice in our setting. […]
Área salud
[Translated article] Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Statement From the Spanish Hair Disorders Group of the Spanish Academy of Dermatology and Venererology (AEDV)
abril 12, 2024
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 115. Núm. 4. (Abril 2024)
Androgenetic alopecia can be challenging to treat due to the wide range of available treatments, most of which are not based on evidence from clinical trials. In addition many of the options do not include […]